NORARAMTIDE
UNII 7YQ5294J86
Substance Identification & Data
This profile provides standardized clinical and technical data for Noraramtide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7YQ5294J86.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2580150-96-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
7YQ5294J86
2580150-96-3
N/A
Detailed Substance Profile
Preferred Name
NORARAMTIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C210H300N48O65S3 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
MPUUPFIIXNZYOV-MIGWSOMKSA-N Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12865
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
KL-90
Identifier assigned by the United States Adopted Names Council.
Substance Type
Noraramtide
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@H](NC(=O)CNC(=O)CNC(=O)CC[C@H](C(=O)O)NC(=O)CC[C@H](C(O)=O)NC(=O)[C@H](NC(CC[C@H](C(=O)O)NC(=O)CC[C@@H](C(O)=O)NC(CNC(=O)C1CCN(C(OC[C@H]2[C@]3(CCc4nnn(c4CC[C@]32[H])CCOCCOCCOCCOCCOCCOCCNC(=O)[C@H]5NC(=O)[C@@H](NC(=O)[C@H](CCCCC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(CSC5)=O)C)CCCNC(N)=N)CCCCC)Cc6ccc(O)cc6)Cc7[nH]cnc7)CC(O)=O)=O)C(C)C)CC(C)C)Cc8ccc(-c9ccccc9)cc8)CC(O)=O)[H])=O)CC1)=O)=O)CCC(O)=O)(CC(=O)O)C(=O)N[C@H]%10CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC%10=O)C)Cc%11c[nH]c%12c%11cccc%12)Cc%13c[nH]cn%13)CC(C)C)=O)CCC(O)=O)CC(C)C)C(C)C)Cc%14c[nH]c%15ccccc%15%14)C(N[C@H](C(O)=O)[C@H](O)C)=O
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Noraramtide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
Noraramtide
Common Names & Synonyms
NORARAMTIDE [USAN]
noraramtide [INN]
Systematic Nomenclature
(2R)-2-[[(4R)-4-[[(2R)-2-[[(4R)-4-[[(4S)-4-[[2-[[1-[[(4R,5R,6S)-12-[2-[2-[2-[2-[2-[2-[2-[[(3R,6S,9S,12S,15S,18S,24S,27S,30S,33S,36S,39S)-36-(3-carbamimidamidopropyl)-6,24-bis(carboxymethyl)-30-[(4-hydroxyphenyl)methyl]-27-(1H-imidazol-5-ylmethyl)-39-methyl-15-(2-methylpropyl)-5,8,11,14,17,20,23,26,29,32,35,38,41-tridecaoxo-9,33-dipentyl-12-[(4-phenylphenyl)methyl]-18-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracontane-3-carbonyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]-10,11,12-triazatricyclo[7.3.0.04,6]dodeca-1(9),10-dien-5-yl]methoxycarbonyl]piperidine-4-carbonyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-5-[[2-[[2-[[(2S)-3-carboxy-1-[[(4R,7S,10S,13S,16S,22S,25S,28S,31S,34R)-16-(2-carboxyethyl)-4-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]-25-(1H-imidazol-4-ylmethyl)-7,28-bis(1H-indol-3-ylmethyl)-31-methyl-13,22-bis(2-methylpropyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacont-34-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid
L-Threonine, N-(2-mercaptoacetyl)-L-alanyl-L-arginyl-(2S)-2-aminoheptanoyl-L-tyrosyl-L-histidyl-L-α-aspartylglycyl-L-valyl-L-leucyl-3-[1,1′-biphenyl]-4-yl-L-alanyl-(2S)-2-aminoheptanoyl-L-α-aspartyl-L-cysteinyl-1-[[[1-(20-amino-3,6,9,12,15,18-hexaoxaeicos-1-yl)-1,4,5,5a,6,6a,7,8-octahydrocyclopropa[5,6]cycloocta[1,2-d]-1,2,3-triazol-6-yl]methoxy]carbonyl]-4-piperidinecarbonylglycyl-D-γ-glutamyl-D-γ-glutamyl-D-α-glutamyl-D-γ-glutamyl-D-γ-glutamylglycylglycyl-L-α-aspartyl-L-cysteinyl-L-alanyl-L-tryptophyl-L-histidyl-L-leucylglycyl-L-α-glutamyl-L-leucyl-L-valyl-L-tryptophyl-L-cysteinyl-, cyclic (1→13)-thioether, cyclic (24→34)-disulfide
N-(2-Mercaptoacetyl)-L-alanyl-L-arginyl-(2S)-2-aminoheptanoyl-L-tyrosyl-L-histidyl-L-α-aspartylglycyl-L-valyl-L-leucyl-3-[1,1'-biphenyl]-4-yl-L-alanyl-(2S)-2-aminoheptanoyl-L-α-aspartyl-L-cysteinyl-1-[[[1-(20-amino-3,6,9,12,15,18-hexaoxaeicos-1-yl)-1,4,5,5a,6,6a,7,8-octahydrocyclopropa[5,6]cycloocta[1,2-d]-1,2,3-triazol-6-yl]methoxy]carbonyl]-4-piperidinecarbonylglycyl-D-γ-glutamyl-D-γ-glutamyl-D-α-glutamyl-D-γ-glutamyl-D-γ-glutamylglycylglycyl-L-α-aspartyl-L-cysteinyl-L-alanyl-L-tryptophyl-L-histidyl-L-leucylglycyl-L-α-glutamyl-L-leucyl-L-valyl-L-tryptophyl-L-cysteinyl-L-threonine, cyclic (1→13)-thioether, cyclic (24→34)-disulfide
Technical Codes
BHV-1100
KP-1237
KP1237
